Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01630447

Genetic and Functional Analysis of Cherubism

The goal of this research study is to identify genes and regulatory elements on chromosomes that cause cherubism. Together with the investigators collaborators the investigators also study blood samples and tissue samples from patients to learn about the processes that lead to this disorder. The long-term goal of researchers involved in this study is to find mechanisms to slow down bone resorption in cherubism patients.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Connecticut Health Center

Farmington, Connecticut, 06030, United States

Location status: Recruiting

Location contact

Ernst J Reichenberger, PhD

CONTACT

[email protected]

860-679-2062

About this study

Cherubism is a very rare bone disorder where bone gets excessively resorbed only in the jaw bones (mandible and maxilla). The resulting cavities in bone fill up with soft fibrous (fibro-osseous) tissues that can expand and push the bony shells apart. Thus the characteristic facial appearance in patients with progressed cherubism. Bone resorption (cherubism lesions) in this disorder occurs always symmetrically in the mandible, the maxilla or in both. This distinguishes cherubism from similar disorders. As cherubism progresses, the lesions can invade the eye sockets (inferior and/or lateral orbital walls) and displace the eye balls and push down the eyelids. As a result the sclera (white of the eye) below the iris becomes visible and patients have an upward gazing appearance (cherubic look) which gave the name to this fibro-proliferative bone disorder.

Cherubism typically appears between ages of 2-7 years. It is often diagnosed during dental evaluations. At early stages cherubism is accompanied by lymph node swelling. Proliferation of the fibro-osseous tissue typically stops after puberty and in many the soft tissue in the cherubic bone cavities are replaced by new bone.

For this study we will:

  • Send out study participation kits and consent by phone
  • Collect a saliva sample from eligible individuals
  • Obtain information regarding cherubism
  • Document disorder with photos and doctor's letters
  • If patients undergo surgery for cherubism we ask to obtain some bone tissue that would otherwise be discarded
  • Isolate DNA from the saliva sample
  • Perform genetic analyses of the DNA with the most up-to-date methods available to identify genetic variations
  • Study in the laboratory why the genetic variations cause the disorder

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • cherubism; unaffected individuals only if part of a participating cherubism family

Exclusion criteria

  • no cherubism unaffected individuals only as part of a participating cherubism family

Treatment and study plan

Primary outcomes

  1. Identification of genetic elements

    Time frame: at time of identification

    The goal is to identify relevant genes or genetic elements that cause the disease or contribute to the disease progression and severity.

Study contacts

Contact information is provided by the study sponsor or research team.

Ernst J Reichenberger, PhD

CONTACT

[email protected]

860-679-2062

Sponsors and collaborators

Lead sponsor

UConn Health

Other

Registry information

Official study title

Identification of Mutations That Lead to Cherubism in Families and Isolated Cases and Studies of Cellular and Molecular Mechanisms

Acronym: CBM

Important dates

Study start
2009
Primary completion
2030
Study completion
2030
First posted
Jun 28, 2012
Registry last updated
Apr 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.